GlassScriptPhysician profile
Shervin V Oskouei
NPI 1124120852
$47,512.08
in general payments reported to CMS, 2019-2025
21 companies · $533 in 2025
The $533 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,844 · 2020: $30K · 2021: $6,598 · 2022: $5,106 · 2023: $1,479 · 2024: $991 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,998 · Consulting Fee: $962 · Education: $43.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,998.03 |
| Consulting Fee | $962.00 |
| Education | $43.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Limacorporate S.P.A. | $27,087.07 | 2020-2023 | Lantern Surgical Assistant |
| Lima USA, INC. | $8,583.43 | 2019-2020 | |
| Onkos Surgical, INC. | $7,828.02 | 2019-2025 | Eleos Limb Salvage System |
| Uoc USA INC | $954.33 | 2021-2022 | |
| Shalby Advanced Technologies, INC. | $740.25 | 2021-2024 | Consensus Knee System, Cks - Vitalite, Consensus Hip System |
| Smith+Nephew, INC. | $389.93 | 2022-2024 | Real Intelligence, Journey II, Legion Revision |
| Cerapedics INC. | $274.80 | 2024-2025 | I-Factor Peptide Enhanced Bone Graft |
| Aadi Bioscience, INC. | $243.91 | 2024-2025 | Fyarro |
| Tracpatch Health, INC | $185.21 | 2019 | |
| Carbofix Orthopedics INC | $182.00 | 2023 | |
| Bone Support INC. | $170.83 | 2020-2021 | |
| United Orthopedics LLC | $160.49 | 2022 | |
| Stryker Corporation | $159.47 | 2022-2025 | Mako |
| Medtronic, INC. | $158.54 | 2024 | Osteocool Rf Ablation System |
| Inari Medical, INC. | $107.32 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $89.95 | 2019-2022 | |
| Integrum INC. | $83.53 | 2022-2023 | Opra Implant System |
| Astrazeneca Pharmaceuticals LP | $43.25 | 2025 | Enhertu |
| Carbofix Spine INC | $30.00 | 2023 | |
| Heron Therapeutics, INC. | $22.12 | 2022 | |
| Convatec INC. | $17.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shervin Oskouei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.